Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases

Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases

US Patent 10266548 · Granted Apr 23, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

MASP inhibitory compounds and uses thereof2025
1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseas2025
Acyl sulfonamides for treating cancer2025
Methods of preparing macrocyclic indoles2025
Dihydrooxadiazinones2025
3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridi2025
3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridi2025
Macrocyclic fluorine substituted indole derivatives2024
Macrocyclic fluorine substituted indole derivatives2024
Compounds, compositions and methods for cancer patient stratification and cancer2024
Compounds, compositions and methods for cancer patient stratification and cancer2024
Compounds, compositions and methods for cancer patient stratification and cancer2024